PharVision Advisers’s Omega Healthcare OHI Stock Holding History

PharVision Advisers’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,667	Closed	-$207K	–	482
2025 Q4	$207K	Sell	4,667 -4,489	-49%	-$193K	0.1%	531
2025 Q3	$387K	Buy	+9,156	New	+$369K	0.22%	95

Other funds holding OHI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PharVision Advisers's OHI Position: Q1 2026 in Review

PharVision Advisers sold out of Omega Healthcare (OHI) in Q1 2026, closing a stake of 4,667 shares — an estimated $207K sold.

PharVision Advisers first reported a position in OHI in Q3 2025 and held it in 2 quarters. The position peaked at $387K in Q3 2025. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

PharVision Advisers reported no remaining Omega Healthcare position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,667 Omega Healthcare shares in Q1 2026, an estimated $207K.
PharVision Advisers first reported a position in Omega Healthcare in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Omega Healthcare position peaked at $387K in Q3 2025.
743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.